YTA7 Antibody

What is YTA7 and why is it significant for chromatin research?

YTA7 is a highly conserved bromodomain-containing protein with AAA-ATPase homology that was originally identified for its role in heterochromatin boundary function in Saccharomyces cerevisiae (yeast) . Its significance stems from its direct involvement in regulating nucleosome density and transcriptional activation. YTA7 modulates the amount of DNA-bound histone H3, independent of changes in H3 RNA levels, suggesting it plays a critical role in histone eviction or degradation during transcription . The human ortholog of YTA7, known as ATPase Nuclear Coactivator Cancer-Associated (ANCCA), functions as a coactivator of estrogen and androgen receptors, with increased expression associated with poor prognosis in breast and prostate cancers . Understanding YTA7 function provides insight into fundamental chromatin regulatory mechanisms that are conserved from yeast to humans.

What are the key structural domains of YTA7 protein relevant to antibody targeting?

YTA7 contains several distinct domains that are important considerations for antibody development and experimental design:

• A noncanonical bromodomain that preferentially interacts with unacetylated and unmethylated N-terminal tail of histone H3

• An acidic N-terminal region that serves as a second histone interaction domain

• A putative AAA-ATPase domain of the NSF/Cdc48/Pex family, which contains the conserved Walker-A motif (GxxxxGKT) that is critical for ATP hydrolysis

When designing or selecting YTA7 antibodies, researchers should consider which domain they want to target based on their experimental goals. Antibodies targeting different domains may yield different results in various applications, particularly if post-translational modifications or protein-protein interactions mask specific epitopes.

What techniques commonly employ YTA7 antibodies in chromatin research?

YTA7 antibodies are utilized in several key chromatin research techniques:

• Western blotting: For detecting YTA7 protein levels, molecular weight, and potential post-translational modifications

• Chromatin Immunoprecipitation (ChIP): For analyzing YTA7 localization at specific genomic loci, particularly at highly transcribed genes and upon transcriptional induction

• Co-Immunoprecipitation (Co-IP): For studying protein-protein interactions, such as the interaction between YTA7 and RNA Polymerase II

• Immunofluorescence microscopy: For visualizing YTA7 localization within cellular compartments

• Tandem Affinity Purification (TAP): Often using YTA7-TAP tagged proteins for purification and subsequent analysis of protein complexes

Each technique requires specific antibody characteristics, including high specificity, appropriate affinity, and compatibility with the experimental conditions being employed.

How should researchers validate YTA7 antibody specificity for chromatin studies?

Validating YTA7 antibody specificity is critical for obtaining reliable results in chromatin studies. A comprehensive validation approach should include:

• Genetic controls: Compare results between wild-type cells and yta7Δ mutants to confirm signal absence in knockout strains

• Peptide competition assays: Pre-incubate the antibody with purified YTA7 peptides to demonstrate specific blocking of signal

• Tag-based validation: Compare results between native YTA7 antibodies and antibodies against tagged versions (e.g., YTA7-TAP)

• Cross-reactivity assessment: Test antibodies against related proteins, particularly those with similar domains (other bromodomain-containing proteins)

• Application-specific validation: Confirm specificity in each specific application (Western blot, ChIP, immunofluorescence)

Additionally, researchers should be aware that post-translational modifications of YTA7, particularly phosphorylation during the cell cycle, may affect antibody recognition . Multiple antibodies targeting different epitopes can provide more comprehensive and reliable results.

What are the optimal ChIP conditions for studying YTA7 binding to chromatin?

Optimizing ChIP conditions for YTA7 is essential for accurate detection of its chromatin associations:

• Fixation conditions: Use 1% formaldehyde for 15-20 minutes at room temperature for standard crosslinking; consider testing dual crosslinking with DSG (disuccinimidyl glutarate) followed by formaldehyde for enhancing protein-protein interactions

• Sonication parameters: Adjust to generate DNA fragments of 200-500 bp; this is particularly important as YTA7 localizes to specific regions of genes, such as the 5′-ORF regions

• Antibody selection: Choose antibodies validated for ChIP applications; consider using TAP-tagged YTA7 with anti-TAP antibodies for enhanced specificity

• Washing stringency: Balance between removing non-specific interactions and maintaining specific YTA7-chromatin interactions

• Controls: Include input DNA, IgG control, and ideally a yta7Δ strain as a negative control

When analyzing results, compare YTA7 binding at known targets (e.g., highly transcribed genes like FBA1, TEF1, and PMA1) versus non-target regions. For inducible genes like the GAL cluster, perform ChIP before and after induction to capture the dynamic recruitment of YTA7 .

How can researchers effectively monitor YTA7 phosphorylation changes during the cell cycle?

YTA7 undergoes cell cycle-dependent phosphorylation that may affect its function . To effectively monitor these changes:

• Synchronization methods:

  • α-factor arrest (5 mM) for G1 synchronization in yeast

  • Hydroxyurea for S-phase arrest

  • Nocodazole for G2/M arrest

• Detection methods:

  • Western blotting with anti-YTA7 or anti-TAP antibodies (if using YTA7-TAP) to observe mobility shifts

  • Phospho-specific antibodies if available

  • Phos-tag SDS-PAGE for enhanced separation of phosphorylated forms

• Validation approaches:

  • Lambda phosphatase treatment to confirm phosphorylation

  • Comparison with cell cycle markers (e.g., Clb2 for G2/M phase)

  • Mass spectrometry to identify specific phosphorylation sites

• Experimental design considerations:

  • Collect samples at multiple timepoints after release from synchronization

  • Include cell cycle progression controls via budding index or flow cytometry

  • Compare wild-type YTA7 with phospho-mutants if specific sites are known

This approach allows researchers to correlate YTA7 phosphorylation status with its chromatin association and functional activities throughout the cell cycle.

How can researchers dissect the differential roles of YTA7's bromodomain versus AAA-ATPase domain using antibody-based approaches?

Dissecting the roles of YTA7's distinct domains requires sophisticated antibody-based strategies:

• Domain-specific antibodies:

  • Use antibodies targeting specific domains (bromodomain, AAA-ATPase domain)

  • Compare binding patterns in ChIP experiments to identify domain-specific genomic associations

• Mutant-based approaches:

  • Generate strains with point mutations in specific domains (e.g., yta7-K460A in the Walker-A motif of the AAA-ATPase domain)

  • Compare antibody binding and functional readouts between wild-type and mutant strains

  • ChIP-reChIP with domain-specific antibodies to identify subpopulations of YTA7 complexes

• Proximity-based methods:

  • Perform BioID or APEX2 proximity labeling with YTA7 domain-specific fusions

  • Use domain-specific antibodies in PLA (Proximity Ligation Assay) to identify domain-specific interaction partners

• Functional readouts:

  • Monitor histone H3 occupancy changes in response to domain-specific mutations

  • Measure transcriptional outputs at YTA7-dependent genes in domain mutants

These approaches can reveal how each domain contributes to YTA7's ability to modulate nucleosome density and facilitate gene induction.

What are the methodological considerations for studying the interaction between YTA7 and RNA Polymerase II?

The interaction between YTA7 and RNA Polymerase II is functionally significant and requires careful methodological considerations:

• Co-Immunoprecipitation optimization:

  • Test both native conditions and crosslinking approaches

  • Compare antibodies against different RNAPII subunits and phosphorylated forms

  • Include detergent optimization to maintain interactions while reducing background

• ChIP-sequencing approaches:

  • Perform sequential ChIP (ChIP-reChIP) to identify genomic regions where YTA7 and RNAPII co-localize

  • Consider spike-in normalization for quantitative comparisons

  • Integrate with transcriptional data to correlate co-binding with gene activity

• Functional validation:

  • Monitor RNAPII recruitment in wild-type versus yta7Δ strains

  • Compare recruitment between WT YTA7 and ATPase-deficient mutants (yta7-K460A)

  • Assess transcriptional outputs in these genetic backgrounds

• Proteomic approaches:

  • Modified RIME (Rapid Immunoprecipitation Mass spectrometry of Endogenous proteins) to identify specific RNAPII subunits interacting with YTA7

  • Crosslinking mass spectrometry to map interaction interfaces

These approaches can reveal not only if YTA7 and RNAPII interact, but also the mechanistic basis for this interaction and its functional consequences.

How can researchers address antibody cross-reactivity with ANCCA (human YTA7 ortholog) in comparative studies?

When conducting comparative studies between yeast YTA7 and human ANCCA (its ortholog), addressing antibody cross-reactivity is crucial:

• Epitope mapping and selection:

  • Identify conserved versus divergent regions between YTA7 and ANCCA

  • Select antibodies targeting either highly conserved regions (for cross-species studies) or species-specific regions (for selective detection)

  • Validate using recombinant proteins from both species

• Specificity testing:

  • Perform Western blot analysis using recombinant YTA7 and ANCCA proteins

  • Test in knockout/knockdown systems for both proteins

  • Include competition assays with peptides from both proteins

• Cross-species validation:

  • If using YTA7 antibodies in human studies (or vice versa), validate using overexpression systems

  • Perform immunodepletion experiments to confirm specificity

  • Consider epitope-tagged versions for unambiguous detection

• Functional validation across species:

  • Compare chromatin association patterns between YTA7 and ANCCA at orthologous genes

  • Assess functional complementation between species (e.g., can human ANCCA rescue yeast yta7Δ phenotypes?)

This approach ensures reliable comparative studies that can highlight both conserved and divergent functions of these proteins across species.

How should researchers interpret contradictory ChIP data when studying YTA7 localization at different gene regions?

Contradictory ChIP data for YTA7 localization can arise from several factors:

• Biological considerations:

  • YTA7 shows dynamic localization that changes upon transcriptional induction

  • Different gene regions may show variable YTA7 association (e.g., 5′-ORF bias)

  • Cell cycle stage affects YTA7 localization and activity

• Technical considerations:

  • Antibody epitope accessibility may vary across different chromatin states

  • Crosslinking efficiency can differ between promoter and coding regions

  • Sonication bias may affect recovery of different genomic regions

• Interpretation guidelines:

  • Compare data across multiple experimental conditions and time points

  • Use complementary approaches (e.g., TAP-ChIP and native antibody ChIP)

  • Consider the functional state of the gene (induced vs. repressed)

  • Examine histone H3 occupancy in parallel, as YTA7 affects H3 distribution

• Validation approaches:

  • Use sequential ChIP to determine if different subpopulations of YTA7 exist

  • Perform ChIP-seq for genome-wide localization patterns

  • Correlate with functional readouts (e.g., transcription, nucleosome spacing)

Understanding that YTA7 has context-dependent functions can help reconcile apparently contradictory data.

What controls are essential when using YTA7 antibodies to study its role in histone H3 regulation?

When studying YTA7's role in histone H3 regulation, these controls are essential:

• Genetic controls:

  • yta7Δ strain as a negative control

  • ATPase-deficient mutant (yta7-K460A) to distinguish ATP-dependent functions

  • Strains with altered H3/H4 dosage to assess dependency relationships

• ChIP controls:

  • Parallel ChIP for histone H3 to correlate with YTA7 binding

  • Monitor nucleosome spacing in addition to H3 occupancy

  • Include both induced and non-induced conditions for inducible genes

• Expression controls:

  • Measure H3 transcript levels to distinguish transcriptional vs. post-transcriptional effects

  • Monitor total H3 protein levels alongside chromatin-bound H3

  • Assess turnover rates of H3 (e.g., with SNAP-tag or FRAP approaches)

• Functional validation:

  • Test suppression of yta7Δ phenotypes by decreased H3/H4 dosage

  • Evaluate H3 distribution patterns in long inducible genes (e.g., FMP27)

  • Compare Yta7 overexpression effects on H3 levels

These controls help distinguish direct effects of YTA7 on H3 from indirect consequences of altered transcription or other cellular processes.

How can researchers effectively compare data from YTA7 antibodies across different experimental systems (yeast, mammalian cells)?

Comparing YTA7 antibody data across experimental systems requires careful consideration:

• Antibody selection and validation:

  • Validate each antibody specifically in each system

  • For conserved epitopes, confirm equivalent sensitivity and specificity

  • Consider using epitope-tagged versions with a common tag for direct comparisons

• Experimental normalization:

  • Include spike-in controls for quantitative comparisons

  • Normalize to common reference genes or regions

  • Use consistent chromatin preparation methods where possible

• Functional context alignment:

  • Compare orthologous genes rather than arbitrary loci

  • Account for differences in genomic organization and regulatory mechanisms

  • Consider evolutionary conservation of protein interaction partners

• Interpretation guidelines:

  • Focus on mechanistic principles rather than exact binding patterns

  • Evaluate conservation of functions (e.g., H3 regulation, transcriptional effects)

  • Consider system-specific factors (e.g., nucleosome organization differences)

• Complementary approaches:

  • Use orthogonal techniques to validate findings across systems

  • Consider heterologous expression studies (e.g., human ANCCA in yeast)

  • Correlate molecular findings with phenotypic outcomes

This approach allows researchers to distinguish conserved functions from system-specific roles of YTA7/ANCCA.

What are the best approaches for generating and validating phospho-specific YTA7 antibodies?

Generating and validating phospho-specific YTA7 antibodies requires careful consideration:

• Identification of phosphorylation sites:

  • Perform mass spectrometry analysis of purified YTA7 protein from different cell cycle stages

  • Use predictive algorithms to identify likely kinase target sites

  • Consider conservation of phosphorylation sites between species

• Antibody generation strategy:

  • Design phosphopeptides containing the phosphorylated residue of interest

  • Include carrier proteins and appropriate adjuvants

  • Consider generating antibodies recognizing multiple phosphorylation states

• Rigorous validation approach:

  • Test against phosphorylated and non-phosphorylated peptides

  • Validate using wild-type versus phospho-mutant proteins (S/T→A or S/T→E)

  • Perform lambda phosphatase treatment to confirm phospho-specificity

  • Validate timing of phosphorylation during the cell cycle

• Application-specific validation:

  • Confirm specificity in Western blotting, IP, and ChIP applications

  • Test detection limits and linear range of quantification

  • Validate in physiologically relevant conditions (e.g., during cell cycle progression)

Phospho-specific antibodies can reveal how YTA7 phosphorylation correlates with its chromatin association and function in histone regulation throughout the cell cycle.

How can researchers optimize ChIP-seq experiments to capture the dynamic association of YTA7 with transcriptionally active genes?

Optimizing ChIP-seq for YTA7's dynamic association with active genes requires specific considerations:

• Experimental design for capturing dynamics:

  • Include multiple timepoints during gene induction (e.g., for galactose-inducible genes)

  • Consider dual crosslinking to stabilize transient interactions

  • Use spike-in normalization for quantitative comparisons between conditions

• ChIP optimization:

  • Adjust sonication to ensure complete coverage of gene bodies

  • Optimize antibody concentration and incubation conditions

  • Consider targeted ChIP-seq approaches for low-abundance binding sites

• Integrated approaches:

  • Parallel ChIP-seq for histone H3 to correlate with YTA7 binding

  • Include RNA-seq to correlate YTA7 binding with transcriptional output

  • Consider nascent transcription assays (e.g., PRO-seq) to capture active transcription

• Analytical considerations:

  • Use appropriate peak calling algorithms for broad domains

  • Perform metagene analyses centered on transcription start sites

  • Consider gene length as a variable, as YTA7 shows specific patterns at long genes

• Validation strategies:

  • Confirm key findings with ChIP-qPCR at representative loci

  • Test in different genetic backgrounds (e.g., wild-type vs. yta7-K460A)

  • Correlate binding changes with functional outcomes (e.g., H3 occupancy, transcription)

This approach can reveal how YTA7 dynamically associates with genes during transcriptional activation and contributes to histone regulation.

What methodological approaches can distinguish direct versus indirect effects of YTA7 on histone H3 regulation?

Distinguishing direct from indirect effects of YTA7 on histone H3 regulation requires sophisticated methodological approaches:

• In vitro systems:

  • Reconstitute nucleosome disassembly with purified components

  • Test ATPase activity of wild-type YTA7 versus yta7-K460A

  • Measure direct binding affinity to H3 under various conditions

• Rapid depletion systems:

  • Use auxin-inducible degron (AID) tagging of YTA7 for acute depletion

  • Monitor immediate changes in H3 occupancy before secondary effects occur

  • Compare with long-term deletion effects

• Domain-specific approaches:

  • Use separation-of-function mutations that specifically affect H3 binding

  • Test bromodomain mutants versus AAA-ATPase mutants

  • Create chimeric proteins to test domain-specific functions

• Proximity-based methods:

  • Apply APEX2 or BioID to identify proteins in the immediate vicinity of YTA7

  • Use crosslinking mass spectrometry to map direct interaction interfaces

  • Perform ChIP-exo or CUT&RUN for high-resolution mapping of YTA7 binding sites

• Site-specific analysis:

  • Focus on the 3′ end of FMP27 where H3 accumulates in yta7Δ mutants

  • Use MNase-seq to assess nucleosome positioning changes

  • Apply mathematical modeling to distinguish primary from secondary effects

These approaches can help establish a causal relationship between YTA7 activity and H3 regulation, distinguishing direct molecular actions from downstream consequences.